Supreme Court may take up Medtronic case; FDA approves thoracic graft from Cook;

@FiercePharma: India's Sun Pharma makes $48M purchase of eyecare firm InSite Vision. FiercePharmaAsia item | Follow @FiercePharma

@EricPFierce: Ireland pharma biz going to the dogs, so to speak. Nextvet picks up biologics plant there. FiercePharmaManufacturing item | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Perrigo officially rejects Mylan's 'insulting,' 'ego'-driven buyout offer. Item | Follow @CarlyHFierce

> St. Jude ($STJ) nabs CE mark for larger sizes, 27mm and 29mm, of its Portico Transcatheter Aortic Valve Replacement System. More

> Reuters ran a story on startups working on technology to help enable seniors to age at home. Article

> A spinal patient has requested that the U.S. Supreme Court review a ruling against her and in favor of Medtronic ($MDT) over off-label use of the company's Infuse bone graft. More

> Cook Medical has gained a PMA approval for its lower-profile Zenith Alpha Thoracic Endovascular Graft. More

Medical Device News

@FierceMedDev: ICYMI yesterday: U.K. scientists develop ultrasonic device to better clean medical instruments. Article | Follow @FierceMedDev

@EmilyWFierce: Jaychem Industries is feeling the burn from an FDA warning letter over its GolfersSkin Sunscreen. FiercePharmaManufacturing story | Follow @EmilyWFierce

> Penumbra goes public in upsized $120M deal, med tech's largest IPO of 2015. Story

> Upstart Establishment gets $20M+ to bring safer breast implants with nanotech, RFID tracking to U.S. Article

> FDA cautions against improperly cleaned bronchoscope devices. More

Biotech News

@FierceBiotech: RegenX IPO raises $138M, renewing hopes for a big Q4 biotech run. Article | Follow @FierceBiotech

@JohnCFierce: Allergan and Richter win FDA approval for a once-rejected schizophrenia pill. News | Follow @JohnCFierce

> NIH pushes forward in Obama's $215M 'precision medicine' plan. News

> Nabriva pulls off a down-sized IPO, raising $92M for antibiotic R&D. Story

> FierceBiotech Radio on 'amazing' diabetes data, biotech's VC boom, and Severin Schwan's hot mic. More